Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 46,546 $ 83,103
Derivative instruments 45,897  
Other current assets 2,508 1,471
Total current assets 94,951 84,574
Investment in Charter, accounted for using the equity method (note 4) 12,067,329 12,004,376
Other assets 9,767 9,487
Total assets 12,172,047 12,098,437
Current liabilities:    
Accounts payable and accrued liabilities 4,070 3,504
Deferred revenue and other current liabilities 7,734 4,691
Total current liabilities 11,804 8,195
Debt (note 5) 572,619 522,928
Deferred income tax liabilities 972,005 965,829
Other liabilities 3,447 2,867
Total liabilities 1,559,875 1,499,819
Equity    
Preferred stock, $.01 par value. Authorized 50,000,000 shares; no shares issued
Additional paid-in capital 7,926,662 7,938,357
Accumulated other comprehensive earnings, net of taxes 7,778 7,778
Retained earnings 2,675,916 2,650,669
Total equity 10,612,172 10,598,618
Commitments and contingencies (note 7)
Total liabilities and equity 12,172,047 12,098,437
Series A common stock    
Equity    
Common stock 264 263
Series B common stock    
Equity    
Common stock 25 25
Series C common stock    
Equity    
Common stock $ 1,527 $ 1,526